What are the 1-year returns of HDFC Charity Fund For Cancer Cure Direct-IDCW?
HDFC Charity Fund For Cancer Cure Direct-IDCW has delivered a 1-year return of 5.93% as of 16 Jul 2026. During the same period, its benchmark NIFTY Medium Duration Index returned -3.42%. The fund has outperformed its benchmark over this period.
What are the 3-year returns of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The 3-year CAGR for HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Trailing Returns section above.
What are the 5-year returns of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The 5-year CAGR for HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Trailing Returns section above.
What are the returns of HDFC Charity Fund For Cancer Cure Direct-IDCW since inception?
Since its launch on 13 Aug 2023, HDFC Charity Fund For Cancer Cure Direct-IDCW has delivered a CAGR of 7.55%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has HDFC Charity Fund For Cancer Cure Direct-IDCW performed vs its category over the long term?
Category rank for HDFC Charity Fund For Cancer Cure Direct-IDCW on a 3-year and 5-year basis is shown in the Trailing Returns section above.
What is the Sharpe ratio of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The Sharpe ratio of HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Alpha, Beta & Sharpe section above.
What is the alpha of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The alpha of HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Alpha, Beta & Sharpe section above.
What is the beta of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The beta of HDFC Charity Fund For Cancer Cure Direct-IDCW is shown in the Alpha, Beta & Sharpe section above.
What are the rolling returns of HDFC Charity Fund For Cancer Cure Direct-IDCW?
The average 1-year and 3-year rolling returns of HDFC Charity Fund For Cancer Cure Direct-IDCW is 8.22% and - respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.
